'Synthetic cannabis': A dangerous misnomer.
The International journal on drug policy December 1, 2021 Shane Darke, Samuel Banister, Michael Farrell et al.
The term 'synthetic cannabis' is a misnomer for a group of drugs that should instead be called synthetic cannabinoid receptor agonists (SCRAs). These substances differ substantially from delta-9-tetrahydrocannabinol (THC) in pharmacodynamics, mechanisms of action, and physiological effects, exhibiting greater potency and efficacy along with psychostimulant-like properties. The authors argue that the misnomer has negative clinical and public health implications, and that adopting the term SCRAs could reduce confusion and harms. The constant evolution of this drug class requires distinct policy responses regarding terminology, harm reduction, epidemiology, treatment, and legal status.